Dr. Steingo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9970 Central Park Boulevard
Suite 207
Boca Raton, FL 33428Phone+1 561-482-1027- Is this information wrong?
Education & Training
- Baylor College of MedicineResidency, Neurology, 1978 - 1980
- University of the WitwatersrandClass of 1971
- University of the WitwatersrandBS, Microbiology, Biochemistry, 1968
Certifications & Licensure
- FL State Medical License 1980 - 2025
- TX State Medical License 1978 - 1999
- SC State Medical License 1978 - 1982
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Clinical Trials
- Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Start of enrollment: 2011 Sep 08
- Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 14 citationsEfficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies.Bart Van Wijmeersch, Barry A Singer, Aaron Boster, Simon Broadley, Oscar Fernandez, Mark S. Freedman, Guillermo Izquierdo, Jan Lycke, Carlo Pozzilli, Basil Sharrack, B...> ;Multiple Sclerosis. 2020 Nov 1
- 25 citationsLong-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223Brian Steingo, Yaser Al Malik, Ann D Bass, Regina Berkovich, Matthew Carraro, Oscar Fernandez, Carolina Ionete, Luca Massacesi, Sven G. Meuth, Dimos D. Mitsikostas, Ga...> ;Journal of Neurology. 2020 Jun 24
- 34 citationsImmune thrombocytopenia in alemtuzumab-treated MS patients: Incidence, detection, and management.Adam Cuker, Ann D Bass, Congor Nadj, Mark A Agius, Brian Steingo, Krzysztof Selmaj, Timothy Thoits, Alexandre Guerreiro, Bart Van Wijmeersch, Tjalf Ziemssen, Sven G. M...> ;Multiple Sclerosis. 2020 Jan 1
- Join now to see all
Journal Articles
- Impact of a switch to fingolimod versus staying on glatiramer acetate or beta interferons on patient and physician reported outcomes in relapsing multiple sclerosis: p...Calkwood, J., Cree, B., Crayton, H., Kantor, D., Steingo, B., Barbato,L., Hashmonay, R., Agashivala, N., McCague, K., Tenenbaum, N. and Edwards, K, BMC Neurology, 1/1/2014
- Emerging challenges on the therapeutic landscape of multiple sclerosis: The managed care physician’s perspective and medical director’s perspectiveCree, B. A., Steingo, B., Journal of Managed Care Medicine, 1/1/2012
Abstracts/Posters
- Real-world patient retention and satisfaction on fingolimod versus platform injectable disease-modifying therapies in early RRMS: results from PREFERMSHeidi Crayton, Brian Steingo, DeRen Huang, Xiangyi Meng, Lesley Schofield, Kristen Johnson, Nadia Tenenbaum on behalf of the PREFERMS investigators, Sunrise Medical Group, Neurology and Neuroscience Associates, Unity Health Network, Novartis Pharmaceuticals Corporation, 68th Congress of the American Academy of Neurology, Multiple locatoins, 1/1/2016
- Patients of African Descent With Active RRMS Demonstrate Clinical and Radiologic Benefits With Alemtuzumab Over 5 YearsAnnette Okai, Keith R Edwards, Brian Steingo, David H Margolin, Sourav Santra, Mitzi Williams, 2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), Multiple locatoins, 1/1/2016
- No Evidence of Disease Activity for 4 Years Following 2 Courses of Alemtuzumab and No Further Treatment: Long-term Responders From CARE-MS IIEdward J Fox, Hans-Peter Hartung, Eva Havrdova, Brian Steingo, David H Margolin, Karthinathan Thangavelu, Gavin Giovannoni, Central Texas Neurology Consultants, First Medical Faculty, 2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC), Multiple locatoins, 1/1/2016
- Join now to see all
Lectures
- Minimizing Risks and Maximizing Efficacy for Management of Multiple SclerosisCMEducation Resources, LLC, Philadelphia, Pennsylvania - 4/27/2013
- Minimizing Risks and Maximizing Efficacy for Management of Multiple SclerosisCMEducation Resources, LLC, New Orleans, Louisiana - 3/16/2013
- Minimizing Risks and Maximizing Efficacy for Management of Multiple SclerosisCMEducation Resources, LLC, Baltimore, Maryland - 3/9/2013
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Holy Cross HospitalFort Lauderdale, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: